- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS) - The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
- Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and or undergoing percutaneous coronary or valve interventions
A joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS) - 2018 Joint European consensus document on the management of antithrombotic therapy inatrial fibrillation patients presenting with acute coronary syndrome andor undergoing percutaneous cardiovascular interventions
A joint consensus document of the EuropeanHeart Rhythm Association (EHRA), European Society of Cardiology Working Group onThrombosis, European Association of Percutaneous Cardiovascular Interventions(EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the HeartRhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin AmericaHeart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa(CASSA)
Our mission: To reduce the burden of cardiovascular disease.